Nicki Burgess

Nicki Scholes-Robertson is a clinical Physiotherapist who received a live donor transplant in November 2014. Nicki established in 2013 a Renal support group in her town Armidale NSW which continues to meet monthly . In 2015 she received an Operation Angel award from KHA for her contribution to the Renal community . In 2017 Nicki walked 525km , the distance from her home to the RPA hospital to raise money and awareness for her local renal unit and RPATI. Earlier this year she joined the Beat-CKD Consumer advisory board and is an advocate for rural patients with ESRD .

Karen Dwyer

Karen Dwyer is Professor of Medicine and Deputy Head, School of Medicine at Deakin University. Karen trained as a nephrologist and transplant physician at St.Vincent’s Hospital Melbourne. Karen has been a recent council member for the TSANZ and is now the Oceania representative on the TTS Council.

Karen has provided a nephrology outreach service for many years to SouthWest Victoria. She was the lead physician in Australia’s first hand transplant procedure and now chairs the advisory group on Vascularised Composite Allotransplantation for the TSANZ. Her research focus has been in adenosine signalling in transplantation and ischemia reperfusion injury. She is embraking on a clinical research exploring “hot spots” of renal disease in rural and regional Victoria in collaboration with the National Centre for Farmer’s Health.

Karen was awarded the WIT leader in transplantation Award at the International Transplant Congress 2018 for her work on gender equity within TSANZ.

David Johnson

David Johnson is currently Director of the Metro South and Ipswich Nephrology and Transplant Service (MINTS) and Medical Director of the Queensland Renal Transplant Service at Princess Alexandra Hospital, Brisbane, Australia, Professor of Medicine and Professor of Population Health at University of Queensland, and Director of the Centre for Kidney Disease Research, Brisbane, Australia. He has a number of international leadership responsibilities, including President of the International Society for Peritoneal Dialysis, Councillor of the International Society of Nephrology, Co-Chair of the ISN Global Kidney Health Atlas, and Co-Chair of the Global PDOPPS Steering Committee. His national leadership positions include Chair of three separate CARI Guideline Working Groups (Peritoneal Dialysis Adequacy, Evaluation of Renal Function and Management of Early CKD), Chair of the Primary Healthcare Education Advisory Committee to KHA (PEAK – Kidney Check Australia Taskforce), Co-Chair of the Australasian Creatinine and eGFR Consensus Working Party, Co-Chair of the Australasian Proteinuria Consensus Working Party, Deputy Chair of the Australasian Kidney Trials Network, and Member and Past-Chair of the ANZDATA Registry Peritoneal Dialysis Working Group. He was Chair of the Queensland Statewide Renal Clinical Network from 2008 until 2013. He is the principal investigator on a number of large, multi-centre randomised controlled trials, including the balANZ, HERO, IDEAL, IMPENDIA, HONEYPOT and CKD-FIX trials, and is chair of the Data Safety and Monitoring Board for the FINESSE trial. He has published over 780 original manuscripts in peer-reviewed journals and presented over 450 abstracts at national and international scientific meetings. He has won numerous research awards for his clinical and basic science studies in the areas of peritoneal dialysis outcomes, cardiovascular risk factor modification in uraemia, renal transplantation, dialysis unit infection control, treatment of acute kidney injury and mechanisms of progressive chronic kidney disease. In 2005, he was awarded the TJ Neale Award by the Australian and New Zealand Society of Nephrology for “outstanding contributions to nephrologic science.” He was a Queensland finalist in the Australian of the Year Awards for 2009. On Australia Day 2011, he was awarded a Public Service Medal by the Governor-General of Australia for outstanding public service, particularly research into the early detection and management of kidney disease. He also successfully co-ordinated the largest-ever evacuation of dialysis patients in Australia during the Cyclone Yasi crisis in 2011. In 2014, he was awarded an International Distinguished Medal by the US National Kidney Foundation and in 2017 he was awarded the Dimitrios Oreopoulos Award by the Canadian Society of Nephrology.

Vlado Perkovic

Vlado Perkovic is Executive Director of The George Institute, Australia, Professor of Medicine at UNSW Sydney, and a Staff Specialist in Nephrology at the Royal North Shore Hospital. His research focus is in clinical trials and epidemiology, in particular in preventing the progression of kidney disease and its complications. He leads several international clinical trials, and has been involved in developing Australian and global treatment guidelines. He has played a central role in the development of an affordable dialysis system, which was a Eureka Prize finalist in 2017.

Vlado is a member of the National Health and Medical Research Council Principal Committee on Research Translation, and is on the Board of the Australian Clinical Trials Alliance and the Association of Australian Medical Research Institutes. He is Chair of the International Society of Nephrology Advancing Clinical Trials (ISN-ACT) group; and is a Fellow of the Royal Australasian College of Physicians, and the Australian Academy of Health and Medical Sciences. He serves on the Editorial Boards of a number of leading specialist and general journals, including the Journal of the American Society of Nephrology, Circulation, and the New England Journal of Medicine

Charmaine E Lok MD

Charmaine E. Lok, BSc(PT), MD, MSC, FRCP(C) is a Professor of Medicine at the University of Toronto (U of T). She is graduate faculty in the Clinical Epidemiology & Health Care Research Program, Department of Health Policy, Management and Evaluation (U of T) and the Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University. Dr. Lok is the Medical Director of both the multidisciplinary chronic kidney disease (CKD) and hemodialysis programs at the University Health Network-Toronto General Hospital, Toronto, Canada. She is a Senior Scientist at the Toronto General Research Institute with research interests in patient health outcomes and functional ability in CKD, hemodialysis vascular access and cardiovascular disease in endstage renal disease (ESRD). Dr. Lok is also active in raising awareness of CKD and ESKD and its importance in public health. She is involved in a variety of local and international scientific and educational programs, including ASN, CIHR, DOPPS, KFOC, NKF, and Kidney CARE Network International.

Laura Dember MD

Laura M. Dember, M.D. is a Professor of Medicine and Epidemiology at the University of Pennsylvania Perelman School of Medicine where she is a faculty member in the Renal-Electrolyte and Hypertension Division and a Senior Scholar in the Center for Clinical Epidemiology and Biostatistics.  Dr. Dember conducts patient-oriented research in chronic kidney disease and end-stage renal disease and has particular interests in hemodialysis vascular access and interventions to improve clinical outcomes for patients treated with maintenance hemodialysis.  She has leadership roles in several multicenter observational studies and clinical trials including the Dialysis Access Consortium, the Hemodialysis Fistula Maturation Study, the Hemodialysis Novel Therapies Consortium, and the TiME Trial, all funded by the US National Institutes of Health. She has clinical expertise in the systemic amyloidoses and has been involved in the development of new treatment approaches for this group of disorders.  Dr. Dember has been a member of several committees of the American Society of Nephrology and is a Deputy Editor for the American Journal of Kidney Diseases.

Camille Kotton MD

Camille Nelson Kotton MD, FIDSA, FAST is the clinical director of the Transplant Infectious Disease and Immunocompromised Host Program at the Massachusetts General Hospital, and Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts. She is the past chair of The Infectious Disease Community of Practice of The American Society of Transplantation. From 2007-2013, she was the president of The Transplant Infectious Disease Section of The Transplantation Society. Highlights of her time as president include the development of international guidelines on CMV management after solid organ transplant, followed by an updated version, published in Transplantation (2010 and 2013). Her clinical interests include cytomegalovirus, donor-derived infections, zoonoses, and travel and tropical medicine in the transplant setting.

About ANZSN

The ASM is hosted by Australian and New Zealand Society of Nephrology.

The aims of the Society are to promote and support the study of the kidney and urinary tract in health and disease, and to ensure the highest professional standards for the practice of nephrology in Australia and New Zealand.

Conference Managers

Please contact the team at Conference Design with any questions regarding the Annual Scientific Meeting

© 2015 - 2016 Conference Design Pty Ltd